Announcement on the Receipt of the Clinical Trial Approval Notice for Jinzhen Oral Liquid with Increased Indications

About this update from Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

Announcement on the Receipt of the Clinical Trial Approval Notice for Jinzhen Oral Liquid with Increased IndicationsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Kanion Pharmaceutical Co. Ltd. Class A